DeepMed Research

MASSACHUSETTS EYE AND EAR INFIRMARY

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1824-01-01

Employees: -

Market Cap: -

Website: http://www.masseyeandear.org/

Clinical Trials

Auditory Brainstem Implant (ABI) in Pediatric Non-Neurofibromatosis Type 2 Subjects

Not Applicable

Terminated

Conditions: Bilateral Hearing Loss for Causes Other Than Tumors

Interventions: Device: Nucleus 24 (discontinued) and ABI541 Auditory Brainstem Implants (ABI)

First Posted Date: 2013-05-29

Last Posted Date: 2020-06-02

Lead Sponsor: Massachusetts Eye and Ear Infirmary

Target Recruit Count: 9

Registration Number: NCT01864291

Locations: 🇺🇸
Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States

Study to Evaluate the Efficacy of Optical Imaging to Evaluate the Anatomy of the Developing Pediatric Vocal Fold

Completed

Conditions: Vocal Fold Development

Interventions: Procedure: Children Examined with the OCT Probe

First Posted Date: 2013-03-13

Last Posted Date: 2020-05-27

Lead Sponsor: Massachusetts Eye and Ear Infirmary

Target Recruit Count: 557

Registration Number: NCT01810107

Locations: 🇺🇸
Massachusetts Eye and Ear, Boston, Massachusetts, United States

Binocular Treatment of Amblyopia Before and After Strabismus Surgery

Not Applicable

Completed

Conditions: Strabismus
Amblyopia

Interventions: Procedure: Binocular Treatment
Procedure: Sham Binocular Treatment

First Posted Date: 2013-02-15

Last Posted Date: 2017-01-13

Lead Sponsor: Massachusetts Eye and Ear Infirmary

Target Recruit Count: 22

Registration Number: NCT01791946

Locations: 🇺🇸
Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States

Auditory Brainstem Implant (ABI) in Adult Non-Neurofibromatosis Type 2 Subjects

Not Applicable

Terminated

Conditions: Bilateral Hearing Loss for Causes Other Than Tumors

Interventions: Device: Nucleus 24 (discontinued) and ABI541 Auditory Brainstem Implants (ABI)

First Posted Date: 2012-11-29

Last Posted Date: 2020-05-06

Lead Sponsor: Massachusetts Eye and Ear Infirmary

Target Recruit Count: 3

Registration Number: NCT01736267

Locations: 🇺🇸
Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States

Postoperative Ibuprofen and the Risk of Bleeding After Tonsillectomy With or Without Adenoidectomy

Phase 2

Completed

Conditions: Tonsillectomy
Adenoidectomy

Interventions: Drug: Ibuprofen
Drug: Acetaminophen

First Posted Date: 2012-05-25

Last Posted Date: 2018-04-24

Lead Sponsor: Massachusetts Eye and Ear Infirmary

Target Recruit Count: 741

Registration Number: NCT01605903

Locations: 🇺🇸
Brook Army Medical Center, San Antonio, Texas, United States
🇺🇸
Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
🇺🇸
nited States Naval Medical Center, Portsmouth, Portsmouth, Virginia, United States

and more 2 locations

Efficacy of Zylet vs. Lotemax for the Treatment of Ocular Surface Inflammation/MGD/Blepharitis

Phase 4

Completed

Conditions: Posterior Blepharitis
Meibomian Gland Dysfunction

Interventions: Drug: B+L Advanced Eye Relief Lubricant Drop
Drug: Loteprednol/tobramycin
Drug: Loteprednol

First Posted Date: 2011-10-21

Last Posted Date: 2017-08-01

Lead Sponsor: Massachusetts Eye and Ear Infirmary

Target Recruit Count: 60

Registration Number: NCT01456780

Locations: 🇺🇸
Massachusetts Eye & Ear Infirmary, Boston, Massachusetts, United States

Evaluating Perioperative Dexamethasone and the Risk of Bleeding in Tonsillectomy

Not Applicable

Completed

Conditions: Post-operative Hemorrhage

Interventions: Drug: Dexamethasone

First Posted Date: 2011-08-12

Last Posted Date: 2017-07-12

Lead Sponsor: Massachusetts Eye and Ear Infirmary

Target Recruit Count: 314

Registration Number: NCT01415583

Locations: 🇺🇸
Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States

The Effects of Caffeinated Coffee on Intraocular Pressure

Not Applicable

Completed

Conditions: Primary Open Angle Glaucoma

Interventions: Other: Caffeinated Coffee
Other: Decaffeinated Coffee

First Posted Date: 2011-06-02

Last Posted Date: 2012-10-31

Lead Sponsor: Massachusetts Eye and Ear Infirmary

Target Recruit Count: 112

Registration Number: NCT01364207

Locations: 🇺🇸
Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States

Effects of Anti-Glaucoma Medications on the Ocular Surface

Phase 4

Terminated

Conditions: Glaucoma

Interventions: Drug: Travoprost
Drug: Latanoprost

First Posted Date: 2011-03-15

Last Posted Date: 2017-03-16

Lead Sponsor: Massachusetts Eye and Ear Infirmary

Target Recruit Count: 14

Registration Number: NCT01315574

Locations: 🇺🇸
Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States

Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD

Not Applicable

Withdrawn

Conditions: Punctate Inner Choroidopathy (PIC)
Trauma, or Hereditary Eye Diseases
Angioid Streaks
Central Serous Chorioretinopathy (CSC)
Choroidal Neovascularization
Myopia
Multifocal Choroiditis
Ocular Histoplasmosis Syndrome

Interventions: Drug: Bevacizumab (Avastin; Genentech, Inc.)
Drug: Bevacizumab, Dexamethasone, Verteporfin Photodynamic Therapy

First Posted Date: 2010-12-08

Last Posted Date: 2014-01-14

Lead Sponsor: Massachusetts Eye and Ear Infirmary

Registration Number: NCT01256580

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy